CLINICAL TRIALS PROFILE FOR IRRIGATING SOLUTION G IN PLASTIC CONTAINER

All Clinical Trials for IRRIGATING SOLUTION G IN PLASTIC CONTAINER

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00333203 ↗	Next Generation Ophthalmic Irrigating Solution Posterior Segment Study	Completed	Alcon Research	Phase 3	2005-10-01	The purpose of this study is to evaluate the safety of Next Generation Ophthalmic Irrigating Solution (NGOIS) compared to BSS PLUS for use during surgery for removal of epimacular membrane and vitrectomy.
NCT00333268 ↗	Safety and Efficacy of Next Generation Ophthalmic Irrigating Solution Compared to BSS Plus	Completed	Alcon Research	Phase 3	2004-09-01	The purpose of this study is to determine the safety and efficacy of Next Generation Ophthalmic Irrigating Solution (NGOIS) compared to BSS Plus for use during cataract extraction and intra-ocular lens (IOL) implantation.
NCT00346528 ↗	Safety of NGOIS Compared to BSS Plus in Pediatric Patients	Completed	Alcon Research	Phase 3	2006-07-01	To evaluate the Safety of Next Generation Ophthalmic Irrigating Solution compared to BSS Plus for use during cataract surgery in Pediatric patients.

Clinical Trial Conditions for IRRIGATING SOLUTION G IN PLASTIC CONTAINER

Condition Name

Condition Name for IRRIGATING SOLUTION G IN PLASTIC CONTAINER
Intervention	Trials
Cataract	6
Surgical Site Infection	2
Resorption, Root	1

Condition MeSH

Condition MeSH for IRRIGATING SOLUTION G IN PLASTIC CONTAINER
Intervention	Trials
Cataract	7
Surgical Wound Infection	3
Pain, Postoperative	2

Clinical Trial Locations for IRRIGATING SOLUTION G IN PLASTIC CONTAINER

Trials by Country

Trials by Country for IRRIGATING SOLUTION G IN PLASTIC CONTAINER
Location	Trials
United States	6
Pakistan	2
Egypt	2
Mexico	1
Canada	1

Trials by US State

Trials by US State for IRRIGATING SOLUTION G IN PLASTIC CONTAINER
Location	Trials
Texas	3
Missouri	1
Maryland	1
Minnesota	1

Clinical Trial Progress for IRRIGATING SOLUTION G IN PLASTIC CONTAINER

Clinical Trial Phase

Clinical Trial Phase for IRRIGATING SOLUTION G IN PLASTIC CONTAINER
Clinical Trial Phase	Trials
Phase 4	3
Phase 3	4
Phase 2	4

Clinical Trial Status

Clinical Trial Status for IRRIGATING SOLUTION G IN PLASTIC CONTAINER
Clinical Trial Phase	Trials
Completed	9
Recruiting	4
Terminated	2

Clinical Trial Sponsors for IRRIGATING SOLUTION G IN PLASTIC CONTAINER

Sponsor Name

Sponsor Name for IRRIGATING SOLUTION G IN PLASTIC CONTAINER
Sponsor	Trials
Alcon Research	4
Dow University of Health Sciences	2
Cairo University	2

Sponsor Type

Sponsor Type for IRRIGATING SOLUTION G IN PLASTIC CONTAINER
Sponsor	Trials
Other	18
Industry	4

Last updated: April 25, 2026

IRRIGATING SOLUTION G IN PLASTIC CONTAINER: Clinical Trials Update and Market Projection

No clinical trials update or market projection can be produced for “IRRIGATING SOLUTION G IN PLASTIC CONTAINER” from the information provided.

What clinical trials are linked to “IRRIGATING SOLUTION G IN PLASTIC CONTAINER”?

No trial identifiers, sponsor names, investigational molecule/active ingredient, trial registries, study phases, endpoints, or geography were provided. Without those inputs, no accurate mapping to clinical trials can be performed.

What is the market size and forecast for “IRRIGATING SOLUTION G IN PLASTIC CONTAINER”?

No active ingredient, strength, indication set (e.g., urologic irrigation, surgical lavage), regulatory status (OTC/prescription, marketed territories), product form details, manufacturer(s), unit packaging specification, pricing, reimbursement status, or distribution channel information was provided. Without those inputs, no market sizing, segmentation, or forecast can be stated as fact.

What are the commercial drivers and risks for this product category?

No category-defining attributes were provided (active ingredient class, sterility and container specifications, intended use, competitive set, sourcing constraints, or regulatory filings). No drivers or risks can be attributed to the specific named product.

Can we project adoption, uptake, and revenue based on evidence?

No adoption or revenue model can be constructed without at least one of the following: validated target indication and geography, historical sales benchmarks, pricing and reimbursement, or a connected pipeline of trials tied to the product.

Key Takeaways

• A clinical trials update and market projection cannot be produced from the provided product name alone.
• No evidentiary basis is available to identify the active ingredient, indication, regulatory context, or trial history tied to the named product.
• No market sizing, forecast, or unit economics can be stated as fact without product-defining attributes and validated commercial data.

FAQs

1. What does “IRRIGATING SOLUTION G IN PLASTIC CONTAINER” mean for analysis?
   It does not identify an active ingredient, indication, manufacturer, or regulatory filing, so it cannot be uniquely analyzed for trials or market.

2. Where would clinical trials for this product typically be found?
   In trial registries and publications, but no registry IDs or sponsor/active ingredient details are provided here.

3. What market segments would irrigation solutions usually fall into?
   Surgical irrigation and procedure-specific lavage categories, but the intended use for this exact product is not specified.

4. What inputs are required to forecast sales for a drug product?
   Indication, geography, regulatory status, pricing/reimbursement, manufacturing constraints, and historical or benchmark sales.

5. Can a forecast be made without historical sales data?
   Only with a defined competitive set, adoption curve inputs, and trial-to-approval evidence, none of which are provided.

References

[1] None.